WeedWeek's Donnell Alexander and Alex Halperin will be at New West Summit this week. If you see us, say hi.
Mayo Clinic researchers who studied the lungs of Vaping Associated Pulmonary Illness (VAPI) patients found the tissue looked like the chemical burns seen in industrial workers exposed to toxic fumes, or World War I soldiers who inhaled mustard gas.
New England Journal of Medicine, New York Times
"Medical investigators have been unable to identify exactly what is causing the lung damage, or even how many harmful substances are involved. They do not know whether the source is the liquids being vaped, or a toxin released from the materials used to make vaping devices. It is also unclear whether some devices used in vaping may be defective."
The Centers for Disease Control says more than 1,000 cases have been diagnosed and there have been 18 deaths.
With VAPI's exact cause still unknown -- the public health response continues to be muddled.
In Leafly, Bruce Barcott writes the flavored vape ban in Washington state will only make things worse.
In an initiative led by the National Cannabis Industry Association (NCIA), 800 prominent industry figures signed a letter to Congress calling for descheduling cannabis as the only responsible solution to the vape crisis.
Despite it all, licensed THC vape sales are stabilizing in key markets, "for now."
VAPI is also the backdrop of a bitter fight over REC product testing in Massachusetts.
Interested in advertising in the WeedWeek newsletter, website, or podcast? Reach out to our advertising team so we can help you spark up a campaign.
The conservative who matters to the cannabiz right now is Sen. Banking Committee Chair Mike Crapo (R-Id.) who has expressed openness to banking legislation.
Last week, Politico's Zachary Warmbrodt explained how Republicans learned to love a pot bill.
Since 2015, WeedWeek has been the best way to keep up with the Green Rush. WeedWeek's audience includes many of the most influential figures in cannabis because we are editorially independent: Advertisers have no influence on our editorial content.
We publish three free newsletters: 1) WeedWeek by founder Alex Halperin, 2) WeedWeek California by Donnell Alexander and 3)WeedWeek Canada by Jesse Staniforth, as well as theWeedWeek Podcast and original reporting. The original WeedWeek newsletter has 11,000 subscribers.
Tips, comments and complaints about this newsletter to Alex email@example.com.
It's been a rough ride for pot stocks, but Alan Brochstein at New Cannabis Ventures thinks now could be the time to invest:
"While the current market is challenging and could see additional pressure over the next few months, we think this is a great time for long-term investors to consider the sector. For years, we have struggled with the valuations, but they look better than ever"
CEO, Critical Mind Inc., Adelanto CA Affiliations: CA State Bar; Board member, Adelanto Growers Association
Critical Mind, Inc. is a Medical Cannabis Cultivation and Manufacturing Facility located in Adelanto, CA. Providing the highest quality Cannabis products. Compliance without Compromise!
Click here to promote your brand on WeedWeek for only $100/month.
In another nice scoop from Leafly's David Downs, California licensed SoCal company Kushy Punch was busted by the state Department of Consumer Affairs for allegedly running an unlicensed cannabis factory as well as a licensed one.
The company also replaced CEO Jim Patterson with COO Rogelio Choy. Both have backgrounds in tech. Patterson will remain on the company's board.
San Francisco Chronicle
After a three-month invite only program, payment processing giant Square said it would start accepting CBD companies as clients.
A prominent Canadian cardiologist said THC use might increase the risk of blood clots connected to strokes, heart disease and heart failure. 🍁WeedWeek Canada has more.
Leafly has a new "cannabis visualization system," which attempts to take users past the debunked sativa/hybrid/indica spectrum and deliver a richer understanding of the plant. It's pretty to look at, but doesn't get past the basic problem that there's no standardization of strains.
Unlike with, say, wine grapes, cannabis brands remain free to name their product whatever strain they want. Thus it's hard to believe a strain called Gelato will have the effect Leafly says it will have.
For almost two years, it's been my great pleasure to write the Guardian's High Time column, which has now ended. Wonderfully illustrated by George Wylesol, it aimed to be a "grown-up's guide to the cannabis revolution."
The most popular pieces include: The Mature Stoner, You're Not Going to Die: How to survive an edible marijuana overdose, and Cannabis Capitalism: Who is making money in the marijuana industry?
Thanks, as always, for reading.🙏
Since 2015, WeedWeek has been the best way to keep up with the Green Rush. Subscribe to our free newsletters today!